174 related articles for article (PubMed ID: 27031442)
1. Recruitment of CD16(+) monocytes to endothelial cells in response to LPS-treatment and concomitant TNF release is regulated by CX3CR1 and interfered by soluble fractalkine.
Rennert K; Heisig K; Groeger M; Wallert M; Funke H; Lorkowski S; Huber O; Mosig AS
Cytokine; 2016 Jul; 83():41-52. PubMed ID: 27031442
[TBL] [Abstract][Full Text] [Related]
2. Human CD16+ monocytes promote a pro-atherosclerotic endothelial cell phenotype via CX3CR1-CX3CL1 interaction.
Roy-Chowdhury E; Brauns N; Helmke A; Nordlohne J; Bräsen JH; Schmitz J; Volkmann J; Fleig SV; Kusche-Vihrog K; Haller H; von Vietinghoff S
Cardiovasc Res; 2021 May; 117(6):1510-1522. PubMed ID: 32717023
[TBL] [Abstract][Full Text] [Related]
3. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.
Ancuta P; Moses A; Gabuzda D
Immunobiology; 2004; 209(1-2):11-20. PubMed ID: 15481136
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of CD16+ monocytes into synovial tissues is mediated by fractalkine and CX3CR1 in rheumatoid arthritis patients.
Yano R; Yamamura M; Sunahori K; Takasugi K; Yamana J; Kawashima M; Makino H
Acta Med Okayama; 2007 Apr; 61(2):89-98. PubMed ID: 17471309
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1 antitrypsin inhibits fractalkine-mediated monocyte-lung endothelial cell interactions.
Mikosz A; Ni K; Gally F; Pratte KA; Winfree S; Lin Q; Echelman I; Wetmore B; Cao D; Justice MJ; Sandhaus RA; Maier L; Strange C; Bowler RP; Petrache I; Serban KA
Am J Physiol Lung Cell Mol Physiol; 2023 Dec; 325(6):L711-L725. PubMed ID: 37814796
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.
Yang XP; Mattagajasingh S; Su S; Chen G; Cai Z; Fox-Talbot K; Irani K; Becker LC
Circ Res; 2007 Nov; 101(10):1001-8. PubMed ID: 17885215
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.
Ancuta P; Rao R; Moses A; Mehle A; Shaw SK; Luscinskas FW; Gabuzda D
J Exp Med; 2003 Jun; 197(12):1701-7. PubMed ID: 12810688
[TBL] [Abstract][Full Text] [Related]
8. Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models.
Nakatani K; Yoshimoto S; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Hasegawa H; Nose M; Saito Y
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F207-16. PubMed ID: 20410215
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide increases monocyte binding to mesangial cells through fractalkine and its receptor.
Park J; Song KH; Ha H
Transplant Proc; 2012 May; 44(4):1029-31. PubMed ID: 22564617
[TBL] [Abstract][Full Text] [Related]
10. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.
Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE
Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708
[TBL] [Abstract][Full Text] [Related]
13. Genistein suppression of TNF-alpha-induced fractalkine expression in endothelial cells.
Sung MJ; Kim DH; Davaatseren M; Hur HJ; Kim W; Jung YJ; Park SK; Kwon DY
Cell Physiol Biochem; 2010; 26(3):431-40. PubMed ID: 20798528
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells.
Moon SO; Kim W; Sung MJ; Lee S; Kang KP; Kim DH; Lee SY; So JN; Park SK
Mol Pharmacol; 2006 Jul; 70(1):112-9. PubMed ID: 16614140
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.
Zanchi C; Zoja C; Morigi M; Valsecchi F; Liu XY; Rottoli D; Locatelli M; Buelli S; Pezzotta A; Mapelli P; Geelen J; Remuzzi G; Hawiger J
J Immunol; 2008 Jul; 181(2):1460-9. PubMed ID: 18606701
[TBL] [Abstract][Full Text] [Related]
16. High-mannose intercellular adhesion molecule-1 enhances CD16
Regal-McDonald K; Xu B; Barnes JW; Patel RP
Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H1028-H1038. PubMed ID: 31398058
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris.
Ikejima H; Imanishi T; Tsujioka H; Kashiwagi M; Kuroi A; Tanimoto T; Kitabata H; Ishibashi K; Komukai K; Takeshita T; Akasaka T
Circ J; 2010 Feb; 74(2):337-45. PubMed ID: 20019415
[TBL] [Abstract][Full Text] [Related]
18. Berberine Suppresses Leukocyte Adherence by Downregulating CX3CL1 Expression and Shedding and ADAM10 in Lipopolysaccharide-Stimulated Vascular Endothelial Cells.
Wu YH; Wei CY; Hong WC; Pang JS
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563195
[TBL] [Abstract][Full Text] [Related]
19. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
Stolla M; Pelisek J; von Brühl ML; Schäfer A; Barocke V; Heider P; Lorenz M; Tirniceriu A; Steinhart A; Bauersachs J; Bray PF; Massberg S; Schulz C
PLoS One; 2012; 7(8):e43572. PubMed ID: 22916279
[TBL] [Abstract][Full Text] [Related]
20. Modulation of inflammatory responses by fractalkine signaling in microglia.
Inoue K; Morimoto H; Ohgidani M; Ueki T
PLoS One; 2021; 16(5):e0252118. PubMed ID: 34019594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
